NewsBusiness

Actions

Troubled Chandler opioid maker sells off drug assets as part of bankruptcy

Posted
and last updated

Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings.

Insys will sell its naloxone and epinephrine nasal sprays and related assets and equipment to Hikma Pharmaceuticals USA Inc. for $17 million, according to a filing with the Securities and Exchange Commission.

Per the purchase agreement, Eatontown, New Jersey- based Hikma agreed to be responsible for cure costs and other specified liabilities.

Insys also will sell its CBD formulations and other products to Chilion Group Holdings US Inc. for $12.2 million, according to the filing.

Read more from the Phoenix Business Journal.